Stem Cell Engineering involves the manipulation, modification, and control of stem cells for various applications in regenerative medicine, disease modelling, drug discovery, and tissue engineering. Stem cells possess unique properties such as self-renewal and differentiation potential, making them promising candidates for therapeutic interventions and biomedical research. One aspect of stem cell engineering involves the generation of induced pluripotent stem cells (iPSCs) through reprogramming somatic cells, such as skin cells or blood cells, into a pluripotent state. iPSCs can differentiate into various cell types found in the body, offering a potentially unlimited source of patient-specific cells for regenerative medicine and disease modelling. Another focus of stem cell engineering is the directed differentiation of stem cells into specific cell lineages, such as neurons, cardiomyocytes, hepatocytes, or pancreatic beta cells. This process involves the use of growth factors, small molecules, and gene editing techniques to induce and control the differentiation of stem cells towards desired cell fates, enabling the generation of functional cell types for transplantation and disease treatment. Genetic engineering of stem cells allows for the modification of their genetic makeup to enhance their therapeutic potential, improve their safety profile, or introduce specific functionalities. Gene editing techniques such as CRISPR-Cas9 can be used to modify the genome of stem cells, enabling precise gene knockouts, insertions, or corrections to correct genetic mutations or engineer desired traits.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States